Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP440485.RA2U-G4j6G37rHMO1zscfQveL57xVGAlVLFjUAHe0CASQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP440485.RA2U-G4j6G37rHMO1zscfQveL57xVGAlVLFjUAHe0CASQ130_assertion type Assertion NP440485.RA2U-G4j6G37rHMO1zscfQveL57xVGAlVLFjUAHe0CASQ130_head.
- NP440485.RA2U-G4j6G37rHMO1zscfQveL57xVGAlVLFjUAHe0CASQ130_assertion wasGeneratedBy ECO_0000203 NP440485.RA2U-G4j6G37rHMO1zscfQveL57xVGAlVLFjUAHe0CASQ130_provenance.
- NP440485.RA2U-G4j6G37rHMO1zscfQveL57xVGAlVLFjUAHe0CASQ130_assertion wasDerivedFrom befree-20140225 NP440485.RA2U-G4j6G37rHMO1zscfQveL57xVGAlVLFjUAHe0CASQ130_provenance.
- NP440485.RA2U-G4j6G37rHMO1zscfQveL57xVGAlVLFjUAHe0CASQ130_assertion SIO_000772 17868191 NP440485.RA2U-G4j6G37rHMO1zscfQveL57xVGAlVLFjUAHe0CASQ130_provenance.
- NP440485.RA2U-G4j6G37rHMO1zscfQveL57xVGAlVLFjUAHe0CASQ130_assertion evidence source_evidence_literature NP440485.RA2U-G4j6G37rHMO1zscfQveL57xVGAlVLFjUAHe0CASQ130_provenance.
- NP440485.RA2U-G4j6G37rHMO1zscfQveL57xVGAlVLFjUAHe0CASQ130_assertion description "[CYP2C19*3 heterozygote alleles are more frequent in patients than in controls (10.2%, 5.6% respectively) and it is related with a three-fold risk of atherosclerosis (odds ratio (OR) = 3.75, confidence interval (CI) = 0.75-18.65).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP440485.RA2U-G4j6G37rHMO1zscfQveL57xVGAlVLFjUAHe0CASQ130_provenance.